Grantham, Mayo, Van Otterloo & Co (GMO)
GMED icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Globus Medical GMED Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.6M Sell
401,717
-18,505
-4% -$1.66M 0.09% 105
2025
Q4 		$36.7M Sell
420,222
-308,216
-42% -$23.4M 0.09% 91
2025
Q3 		$41.7M Buy
728,438
+6,657
+0.9% +$383K 0.12% 91
2025
Q2 		$42.6M Buy
721,781
+132,504
+22% +$8.56M 0.13% 83
2025
Q1 		$43.1M Buy
589,277
+88,793
+18% +$7.34M 0.14% 94
2024
Q4 		$41.4M Sell
500,484
-172,994
-26% -$13.6M 0.13% 94
2024
Q3 		$48.2M Buy
673,478
+87,411
+15% +$6.17M 0.15% 93
2024
Q2 		$40.1M Sell
586,067
-79,986
-12% -$4.78M 0.14% 100
2024
Q1 		$35.7M Buy
666,053
+291,448
+78% +$15.7M 0.13% 112
2023
Q4 		$20M Sell
374,605
-187,838
-33% -$9.15M 0.09% 167
2023
Q3 		$27.9M Buy
562,443
+12,304
+2% +$688K 0.13% 144
2023
Q2 		$32.8M Sell
550,139
-341,887
-38% -$19.5M 0.15% 121
2023
Q1 		$50.5M Buy
892,026
+760,108
+576% +$48.7M 0.26% 73
2022
Q4 		$9.8M Sell
131,918
-25,132
-16% -$1.71M 0.05% 235
2022
Q3 		$9.36M Buy
+157,050
New +$9.46M 0.05% 240

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GMED Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Globus Medical (GMED) stake by 4.4% in Q1 2026, selling an estimated $1.66M and leaving 401,717 shares worth $34.6M. The position accounts for 0.09% of the portfolio, ranked #105.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GMED in Q3 2022 and has held it in 15 quarters since. The position peaked at $50.5M in Q1 2023. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 401,717 shares of Globus Medical worth $34.6M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 18,505 Globus Medical shares in Q1 2026, an estimated $1.66M.
  • Globus Medical made up 0.09% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #105 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Globus Medical in Q3 2022 and has held it in 15 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Globus Medical position peaked at $50.5M in Q1 2023.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.